Travere Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
31.83
|
|
Average Rating
|
4.23
|
|
# Strong Buys
|
7
|
|
# Buys
|
3
|
|
# Holds
|
2
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.86
|
-1.09
|
-0.23
|
-26.74%
|
|
2022-06-30
|
-0.88
|
-1.05
|
-0.17
|
-19.32%
|
|
2022-03-31
|
-0.85
|
-1.20
|
-0.35
|
-41.18%
|
|
2021-12-31
|
-0.68
|
-0.84
|
-0.16
|
-23.53%
|
|
2021-09-30
|
-0.54
|
-0.59
|
-0.05
|
-9.26%
|
|
2021-06-30
|
-0.68
|
-0.64
|
0.04
|
5.88%
|
|
2021-03-31
|
-0.39
|
-0.96
|
-0.57
|
-146.15%
|
|
2020-12-31
|
-0.47
|
-0.48
|
-0.01
|
-2.13%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-3.34
|
|
2021-12-31
|
-3.03
|
|
2020-12-31
|
-1.48
|
|
2019-12-31
|
-3.46
|
|
2018-12-31
|
-2.54
|
|
2017-12-31
|
-1.54
|
|
2016-12-31
|
-1.29
|
|
2015-12-31
|
2.30
|
|
2014-12-31
|
-3.62
|
|
2013-12-31
|
-2.22
|
|
2012-12-31
|
-8.35
|
|
2010-12-31
|
-0.22
|
|
2009-12-31
|
-0.26
|
|
2008-12-31
|
-0.17
|